Quick answer
How do you verify the purity of a research peptide in the lab? Verify three separate things. Purity is the share of the main species among detected species, usually from reversed-phase HPLC with UV detection at 214 to 220 nm. Identity is whether the main species has the expected mass, shown by mass spectrometry. Content is how much of the powder is actually peptide, since counterions and water also weigh something. A single percentage answers only the first. Write acceptance criteria before testing, keep the raw chromatogram and spectrum, and use an independent laboratory when the stakes justify it.
A purity figure on a certificate is one number from one method. Verifying a peptide in your own laboratory, or through a contract laboratory you instruct, means asking which question each analysis answers and what it cannot see. This guide explains the three properties, how a basic RP-HPLC and mass check is set up and read, and how to write an acceptance sheet. It covers analytical practice only. For laboratory research use only; not for human consumption.
Purity, identity and content are different questions
Confusing them is the most common source of misunderstanding about certificates.
| Property | Question | Usual method | What it misses |
|---|---|---|---|
| Purity | What fraction of detected material is the main species? | RP-HPLC with UV detection | Identity; species that do not absorb or that co-elute |
| Identity | Is the main species the intended molecule? | Mass spectrometry; amino-acid analysis or sequencing where needed | Same-mass isomers; relative amounts |
| Net peptide content | How much of the weighed powder is peptide? | Amino-acid analysis, nitrogen or UV against a standard | Purity of that peptide |
| Water content | How much water is in the powder? | Karl Fischer titration | Peptide identity |
| Counterion content | Which salt form and how much? | Ion chromatography, NMR | Peptide purity |
| Endotoxin | Is bacterial endotoxin present? | Limulus-based assays | Peptide quality (Gorbet and Sefton, 2005) |
A vial labeled with a mass of peptide contains that mass of powder, of which some fraction is peptide, some counterion (often trifluoroacetate or acetate from synthesis and purification) and some water. This is why a nominal concentration can be off by a meaningful percentage even when purity is high.
Reversed-phase HPLC: what the purity number is
RP-HPLC separates species by hydrophobicity on a C18 or similar column using a water–acetonitrile gradient with an ion-pairing acid. Peptide bonds absorb strongly near 214 to 220 nm, so detection there reports on nearly all peptide material. The percentage on a certificate is typically the area of the main peak divided by the total area of all integrated peaks. The method's foundations are reviewed by Mant and colleagues (2007). Three consequences follow. The number depends on the gradient, column, wavelength and integration rules, so two valid methods can give different percentages. Co-eluting impurities, such as same-length deletion products with similar hydrophobicity, can hide under the main peak. And species without absorbance at the chosen wavelength are invisible. A chromatogram, not just a number, shows peak shape and baseline, so ask for it. The library's understanding HPLC purity article explains the reading in more detail.
Setting up a basic check
If you run the analysis yourself or brief a contract laboratory, specify the following.
- Sample preparation: solvent, concentration and filtration (a quick filtration can lose peptide at low concentration), kept the same across lots.
- Column and gradient: a column class suitable for the peptide's size and a gradient shallow enough to separate close eluters, with a blank run to identify system peaks.
- Detection: UV at 214 to 220 nm, plus a second wavelength if aromatic residues are present.
- Integration: fixed rules for baseline and threshold, applied identically to every lot.
- Reporting: the full chromatogram, retention time, area percent of each peak and the method parameters.
Running a retained reference lot on the same day makes the comparison meaningful; a change in retention time or peak shape between lots is a signal even when the percentage looks fine.
Confirming identity by mass
Mass spectrometry measures the mass-to-charge ratio of ions, from which the molecular mass is calculated (Aebersold and Mann, 2003 describe the underlying approach). For a peptide, compare the observed mass with the theoretical mass computed from the sequence and any known modifications; agreement within the instrument's tolerance supports identity. Characteristic differences indicate common problems: increments near 16 mass units suggest oxidation, near 1 unit suggest deamidation, and losses of single residues suggest deletion products. Mass alone does not show sequence order, and isomers with the same mass cannot be distinguished, so for critical work add tandem mass spectrometry or amino-acid analysis. Pairing LC with MS lets you identify what each HPLC peak is, which turns a purity number into an impurity profile.
Water, counterions and net content
Peptides are hygroscopic and are usually isolated as salts. The weighed mass therefore overstates peptide mass. Karl Fischer titration quantifies water, ion methods quantify counterions, and amino-acid analysis quantifies the peptide itself. When exact molar concentrations matter, as in receptor binding or dose-response work, use net peptide content to correct the stock concentration, or measure the stock by an absorbance or amino-acid method. The simple formula C = m / V gives a nominal concentration; the calculator and the volume calculation guide cover the arithmetic, and the correction factor is applied on top.
Writing an acceptance sheet
Decide the criteria before the first result arrives, so they cannot be shaped by it.
| Test | Criterion structure | If it fails |
|---|---|---|
| Appearance and solubility | Normal powder; clear solution under defined conditions | Photograph; repeat with fresh vial |
| RP-HPLC purity | Main peak area at or above a stated percentage; no unlisted peak above a stated threshold | Request chromatogram; run LC-MS on the extra peak |
| Identity by MS | Observed mass within tolerance of theoretical | Hold lot; run MS/MS or amino-acid analysis |
| Net content | Within a stated range of nominal | Correct concentration; record the factor |
| Lot documentation | Certificate lot matches vial; method stated | Query the supplier |
For how to read the supplier's side of this record, see how to read a COA, check the COA library for published certificates, and see third-party testing explained for the role of independent laboratories.
When to use an independent laboratory
In-house HPLC is practical for comparing lots with a known reference. Identity by mass, net content and water usually need instruments or methods that a contract laboratory runs routinely. Independent testing is most valuable when the result will support a publication, when a supplier relationship is new, or when a lot behaves unexpectedly. Give the laboratory the sequence, the theoretical mass, the question and the acceptance criteria, and ask for raw data. Sample handling matters: send an unopened vial or an aliquot prepared and stored as you would for an experiment, and record the chain of custody.
Common ways verification goes wrong
Several practical errors recur. Dissolving the sample in a stronger solvent than the starting mobile phase can distort early peaks and mimic impurities. Overloading the column broadens the main peak and hides neighbors. Integrating with different thresholds across lots makes percentages incomparable. Comparing the observed mass with the wrong theoretical value, for example the average mass when the instrument reports monoisotopic values, creates a false mismatch, so state which mass type each number represents. Sending a sample that was stored warm, repeatedly thawed or reconstituted days earlier adds degradation that is then blamed on the supplier. And reading a clean chromatogram as proof of identity ignores that a wrong peptide can also be pure. Writing the method, the sample history and the mass type down avoids most of these. It also helps to run a known standard peptide alongside unknowns on the first occasion a method is used, so that retention time, response and mass accuracy are confirmed before any lot is judged, and to repeat any surprising result on a fresh preparation before drawing a conclusion about the material itself.
Interpreting small impurity peaks
A main peak of high area percent can still sit beside small peaks that matter for a given experiment. Typical synthesis-related impurities include truncated sequences, deletion products, incompletely deprotected species and oxidized forms. Their relevance depends on whether they retain biological activity or interfere with the assay. LC-MS can assign a mass to each small peak and show whether it fits a known pattern, such as a single-residue deletion or a mass increment from oxidation. Reporting the number and size of unassigned peaks, not just the main peak, gives a fuller picture and lets later lots be compared against the same profile.
Where verification fits in the research record
Reagent characterization is part of the reproducibility problem. Surveys of researchers rank unavailable or poorly characterized materials among the factors behind results that cannot be repeated (Baker, 2016), and cost analyses estimate that a large share of preclinical research spending is affected by reagent and protocol problems (Freedman et al., 2015). Keeping the certificate, your own analyses and the lot number with the experimental record is a modest practice with outsized value. The shop lists form, formula and storage for each compound, and the formula gives the theoretical mass to compare with the observed one; for compound-specific testing articles, see the library's semaglutide and BPC-157 guides.
Related reading
- Research shop
- Understanding HPLC purity
- How to read a COA
- Third-party testing explained
- BPC-157 purity testing
- Semaglutide purity testing
- Reconstitution calculator
- COA library
Frequently asked questions
What does an HPLC purity percentage mean?
Usually the area of the main peak as a share of all integrated peaks at a chosen wavelength, under a stated method. It is a chromatographic composition, not a measure of identity or net content.
Is high purity the same as the right molecule?
No. Identity needs a separate confirmation, typically by mass spectrometry compared with the theoretical mass.
What is net peptide content?
The fraction of the weighed powder that is peptide, as opposed to counterions and water.
Why can nominal concentration be off?
Because the labeled mass includes counterions and water, so peptide mass is lower than powder mass.
Can HPLC miss impurities?
Yes. Co-eluting species, same-wavelength-invisible species and aggregates may not be resolved by one method.
What wavelength is used?
Commonly 214 to 220 nm, where the peptide bond absorbs, with a second wavelength if aromatic residues are present.
What do mass differences signal?
Increments near 16 suggest oxidation, near 1 suggest deamidation, and losses of a residue's mass suggest a deletion product.
Do I need an independent laboratory?
Not always. It is most useful for publication-critical work, new supplier relationships and unexpected results.
When should acceptance criteria be written?
Before testing, so they cannot be influenced by the results.
Where can I see published certificates?
In the COA library, where certificates have been published for a lot.
Related reading: The Science of Fat Metabolism: Lipolysis, Oxidation, Storage, Mitochondrial Function and Aging: A Lab Research Guide, Cellular Health: What Researchers Actually Measure.
References
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55. doi:10.1007/978-1-59745-430-8_1
- Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198-207. doi:10.1038/nature01511
- Gorbet MB, Sefton MV. Endotoxin: the uninvited guest. Biomaterials. 2005;26(34):6811-6817. doi:10.1016/j.biomaterials.2005.04.063
- Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533(7604):452-454. doi:10.1038/533452a
- Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165. doi:10.1371/journal.pbio.1002165
